Showing results (1051-1060 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|August 25, 2025
Targeting the Enzymatic Site of Botulinum Neurotoxin Type E With 8-Hydroxyquinolinol-Based Inhibitors: In Silico, In Vitro, and In Vivo EvaluationPriyanka Sonkar, Vinita Chauhan Kushwah, Surabhi Agnihotri, et al.
Drug Development Research|June 17, 2015
Analgesic and anti-inflammatory activities of the ethanol extract of Taxillus tsaii Chiu in miceChia-Yu Liu, Yung-Jia Chiu, Chao-Lin Kuo, et al.
Drug Development Research|June 18, 2015
The Role of miR-21 in CancerSusan R Pfeffer, Chuan He Yang, Lawrence M Pfeffer
Drug Development Research|September 4, 2025
Targeted Inhibition of NOTCH2 and Importin-β Promotes Osteogenic Differentiation of Osteosarcoma CellsZhiyuan Wei, Yan Chen, Guoshi Liu, et al.
Drug Development Research|August 4, 2021
ORY-1001, a KDM1A inhibitor, inhibits proliferation, and promotes apoptosis of triple negative breast cancer cells by inactivating androgen receptorTian Wang, Fulin Zhang, Fulan Sun
Drug Development Research|May 29, 2020
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patientsElisabetta Maffioletti, Paolo Valsecchi, Alessandra Minelli, et al.
Drug Development Research|August 9, 2021
CircTHBS1 facilitates the progression of interstitial cystitis depending on the regulation of miR-139-5p/MFN2 axisChen Jiang, Ming Xu, Jin Zhu, et al.
Drug Development Research|August 9, 2021
MicroRNA-214-5p aggravates sepsis-related acute kidney injury in miceCheng Guo, Fang-Xiong Ye, Yong-Hong Jian, et al.
Drug Development Research|November 19, 2022
Dioscin induces osteosarcoma cell apoptosis by upregulating ROS-mediated P38 MAPK signalingGui-Zhou Zheng, Qi-Hao Zhang, Bo Chang, et al.
Drug Development Research|February 7, 2023
Comparative anticonvulsant activity of the GABAkine KRM-II-81 and a deuterated analogXingjie Ping, Michelle J Meyer, Nicolas M Zahn, et al.
Pageof 138